Loraz and Solodyn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Solodyn (minocycline hydrochloride - er). Common drug interactions include throat irritation among females and nocturia among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Solodyn. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Solodyn?

Solodyn has active ingredients of minocycline hydrochloride - er. It is often used in acne. eHealthMe is studying from 1,011 Solodyn users. Check the latest studies of Solodyn.



On Jul, 09, 2026

16 people who take Loraz and Solodyn together, and have interactions are studied.

Loraz and Solodyn drug interactions.

What are the common drug interactions of Loraz and Solodyn, by gender? *:

female:

  1. Throat irritation
  2. Bronchopulmonary aspergillosis allergic (allergic lung disorder caused by aspergillus fungi)
  3. Cough
  4. Hepatic enzyme increased
  5. Influenza
  6. Rash
  7. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  8. Arthralgia (joint pain)
  9. Bipolar disorder (mood disorder)
  10. Chronic kidney disease

male:

  1. Nocturia (the need to get up in the night to urinate)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Sleep disorder
  7. Surgery
  8. Abdominal discomfort
  9. Activities of daily living impaired
  10. Asthenia (weakness)

What are the common drug interactions of Loraz and Solodyn, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Bronchopulmonary aspergillosis allergic (allergic lung disorder caused by aspergillus fungi)
  2. Cough
  3. Throat irritation
  4. Malaise (a feeling of general discomfort or uneasiness)

20-29:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Surgery
  3. Arthralgia (joint pain)
  4. Lupus-like syndrome (a disease symptom matches with lupus an immune disease)

30-39:

  1. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  2. Dysphonia (speech disorder attributable to a disorder of phonation)
  3. Lower respiratory tract infection
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Productive cough
  6. Respiratory tract congestion (blockage on respiratory system)
  7. Throat irritation
  8. Bipolar disorder (mood disorder)
  9. Dyskinesia (abnormality or impairment of voluntary movement)
  10. Hepatic enzyme increased

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

60+:

  1. Pneumonia

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 43.75%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 18.75%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
  4. Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 12.50%
  5. Seasonal Allergy (allergic condition due to certain season): 2 people, 12.50%
  6. Asthma: 2 people, 12.50%
  7. Bipolar Disorder (mood disorder): 2 people, 12.50%
  8. Constipation: 2 people, 12.50%
  9. Cystic Fibrosis (disease of the secretary glands): 2 people, 12.50%
  10. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Solodyn?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Solodyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Solodyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solodyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and minocycline hydrochloride - er (the active ingredients of Loraz and Solodyn, respectively), and Loraz and Solodyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: